K.AI

K.AI

Em análise

Nominativa · Brasil

TecnologiaComércio e serviçosSoftware e TI

Marca em análise: acompanhe a evolução

A marca "K.AI" ainda está em análise e o status pode mudar. Se o nome é próximo ao seu, pode ser útil acompanhar o desfecho e os despachos publicados.

Panorama da marca

Situação INPI
Publicação de pedido de registro para oposição (exame formal de designação concluído)
Idade do processo
6 meses
Eventos no processo
2
Última atualização
28 de julho de 2026

Dados do processo

Titular
Körber Pharma Software GmbH
Procurador
Dannemann, Siemsen, Bigler & Ipanema Moreira, Propriedade Industrial LTDA
Número do processo
501905055
Número de registro
501905055
Natureza
Madri Produto/Serviço
Data do depósito
09 de janeiro de 2026

Produtos e serviços cobertos

Classe 9Tecnologia

Software for a manufacturing execution system (MES) in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; software for recording, analysing, processing, presenting and managing production data, in particular production data from or for a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular a chatbot in the form of a digital avatar being an interactive helper, in particular using artificial intelligence; software for assistance in compliance, quality control and documentation processes in a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; software for text analysis, voice recognition and voice response, in particular in connection with the creation, processing, adaptation, maintenance, providing, development and/or verification management of electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process; software for text analysis, voice recognition and voice response for the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically software for use with artificial intelligence; artificial-intelligence-based software for a manufacturing execution system (MES) in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; artificial-intelligence-based software for recording, analysing, processing, presenting and managing production data, in particular production data from or for a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular a chatbot in the form of a digital avatar being an interactive helper, in particular using artificial intelligence; artificial-intelligence-based software for assistance in compliance, quality control and documentation processes in a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; artificial-intelligence-based software for text analysis, voice recognition and voice response, in particular in connection with the creation, processing, adaptation, maintenance, providing, development and/or verification management of electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process; chatbots with artificial-intelligence-based software for a manufacturing execution system (MES) in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; chatbots with artificial-intelligence-based software for recording, analysing, processing, presenting and managing production data, in particular production data from or for a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular a chatbot in the form of a digital avatar being an interactive helper, in particular using artificial intelligence; chatbots with artificial-intelligence-based software for assistance in compliance, quality control and documentation processes in a manufacturing execution system (MES), in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines; chatbots with artificial-intelligence-based software for text analysis, voice recognition and voice response, in particular in connection with the creation, processing, adaptation, maintenance, providing, development and/or verification management of electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process; chatbots for assistance in production and quality control processes, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, in particular a chatbot in the form of a digital avatar being an interactive helper; chatbots for assistance in maintenance and verification processes, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, in particular in the form of a digital avatar being an interactive helper; chatbots for controlling industrial processes, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for analysing company and process data, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for data and file management and for databases, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for [process] data management, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for [process] data visualisation, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for automated reporting, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for controlling machines, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for managing supply chains, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for factory automation, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; downloadable mobile applications, in particular for the transmission of information in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for mobile devices, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for robot process automation [RPA] in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for industrial automation, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for production management systems, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for cell and gene therapy production, in particular chatbots using artificial intelligence; chatbots for quality control and assurance, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for documenting and reporting production processes, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for product lifecycle management, in particular in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for the development of medicines and agents in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; chatbots for process development in medicine manufacturing in the pharmaceutical industry or biotech industry, in particular in the field of manufacturing pharmaceutical agents and medicines, more specifically chatbots using artificial intelligence; software; computer software packages; artificial intelligence software; artificial intelligence software for healthcare; artificial intelligence software, in particular for use in the pharmaceutical industry or biotech industry.;

Classe 35Comércio e serviços

Marketing; publicity and sales promotion services; development of marketing strategies and concepts; public relations services; publicity; marketing services; business consultancy in the field of optimisation of documentation processes; consultancy relating to business processes for regulatory compliance in the field of good manufacturing practice (GMP); consultancy relating to the implementation of quality assurance processes in companies; assistance in the automation of processes in the pharmaceutical sectors, in particular in the field of manufacturing pharmaceutical agents and medicines, in particular relating to the automation of processes in connection with electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process; business consultancy in the field of process automation in the pharmaceutical industry; assistance in quality and compliance processes through automated communication and data analysis in the pharmaceutical sector, in particular in the field of manufacturing pharmaceutical agents and medicines; assistance in qualification and/or validation processes in the pharmaceutical sector, in particular in the field of manufacturing pharmaceutical agents and medicines.;

Classe 42Software e TI

Development, providing and maintenance of software featuring chatbot integration for assistance in the creation, processing, adaptation, maintenance, providing, development and/or verification management of electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process, in particular manufacturing execution software (MES); optimisation of software for the development, providing and maintenance of software featuring chatbot integration for assistance in the creation, processing, adaptation, maintenance, providing, development and/or verification management of electronic batch records (EBR), a batch record review (BRR), master batch records (MBR) or a track and trace process, in particular manufacturing execution software (MES); software creation; software customisation services; software development; custom design of software packages; technological consultancy in connection with the development and implementation of digital solutions for GMP-compliant documentation processes; development and implementation of software solutions for electronic documentation according to GMP standards; providing of software as service (SaaS) for GMP-compliant documentation.;

Linha do tempo do processo

2 eventos

Movimentações mais recentes da marca “K.AI” publicadas na Revista da Propriedade Industrial (RPI). O detalhe de cada despacho fica na consulta completa.

  1. Ação / prazo28 de jul. de 2026RPI 2899

    Publicação de pedido de registro para oposição (exame formal de designação concluído)

    Detalhes na consulta completa
  2. Andamento21 de jul. de 2026RPI 2898

    Deferimento da petição

    Detalhes na consulta completa

O que fazer se a sua marca se aproxima de "K.AI"?

Conflitos de marcas no Brasil são resolvidos com base na anterioridade do depósito, nas classes de Nice e no segmento de atuação. O processo tem várias fases e pode ficar complexo quando o nome é parecido ou o mercado se cruza. Uma leitura cuidadosa ajuda a decidir se vale seguir, ajustar ou recuar.

A TrademarkIQ cruza histórico, decisões e padrões de aprovação por classe e setor em uma base com +6 milhões de processos brasileiros. Isso ajuda a enxergar o risco com mais contexto e a encontrar o melhor caminho comercial e jurídico para a sua marca.

Vigilância de marca

Seja avisado antes que vire problema

Monitoramento contínuo: receba um alerta a cada novo depósito que possa colidir com K.AI ou com a sua marca — a tempo de se opor dentro do prazo.

Monitorar marca

Dados actualizados a partir de uma base com +6 milhões de marcas brasileiras analisadas. Esta página é informativa e não substitui parecer jurídico, mas ajuda a orientar a decisão com mais contexto comercial e técnico.